Geneplus locks onto targeted medicine for IPO pitch
After a post-Covid earnings dip, the company is seeking a stable future as a provider of data and diagnostics for precision medicine and disease prevention Key Takeaways: The company’s…
Recent Articles
RELATED ARTICLES
-
Dongshan Precision offers investors an acquisitive, but debt heavy, tech component play
002384.SHE - IPO hopeful Distinct Healthcare targets the well-to-do market
- WUS Printed Circuit charges up Hong Kong’s growing tech pool
- Declining revenues, widening losses remove polish from Hiducation IPO
- Fresh from its first profit, Medcaptain steps into IPO spotlight
-
Years of losses, thin profit margins leave 160 Health feeling down
2656.HK
-
Neglected Burning Rock charms investors with high margins, narrowing losses
BNR.US
